What Influences Patient Outcome in Obstructive Airway Disease?

This study has been completed.

Sponsor:

Information provided by:

University of Dundee

ClinicalTrials.gov Identifier:

NCT01221480

First received: October 14, 2010

Last updated: October 19, 2010

Last verified: October 2010

History of Changes

Tracking Information
First Received Date ^ICMJE	October 14, 2010
Last Updated Date	October 19, 2010
Start Date ^ICMJE	August 2010
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE (submitted: October 14, 2010)	All-cause Mortality
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	Complete list of historical versions of study NCT01221480 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE (submitted: October 14, 2010)	Hospital Admissions COPD exacerbations
Original Secondary Outcome Measures ^ICMJE	Same as current
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	What Influences Patient Outcome in Obstructive Airway Disease?
Official Title ^ICMJE	Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
Brief Summary	The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Retrospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Probability Sample
Study Population	COPD patients within NHS Tayside, UK
Condition ^ICMJE	COPD
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Beta Blocker Use No beta blocker use
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	5977
Completion Date	October 2010
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: Data collected through TARDIS database Exclusion Criteria: History of asthma or malignancy. Less than 50 years of age
Gender	Both
Ages	50 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Not Provided

Administrative Information
NCT Number ^ICMJE	NCT01221480
Other Study ID Numbers ^ICMJE	SHO002
Has Data Monitoring Committee	No
Responsible Party	Dr Philip M Short, University of Dundee
Study Sponsor ^ICMJE	University of Dundee
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	University of Dundee
Verification Date	October 2010
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top